STOCK TITAN
  1. Home
  2. News
  3. AUPH

Aurinia Pharmaceuticals Inc - AUPH STOCK NEWS

IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 2, 2023
earnings
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2023 and 2023 American College of Rheumatology Convergence (ACR)
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director And Enters Cooperation Agreement with Shareholder MKT Capital
management
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Appoints Two New Board Directors with Deep Experience in BioPharma Leadership, Commercial Strategy, Mergers and Acquisitions and Advancing Therapeutic Pipelines
management acquisition
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
earnings
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 3, 2023
earnings
IMPACT
SENTIMENT
AUPH : Nasdaq
Long Term Phase 3 Data Published in Arthritis & Rheumatology Shows LUPKYNIS® (voclosporin) Preserved Kidney Function Up to Three Years in Lupus Nephritis Patients with No New or Unexpected Adverse Events
clinical trial
IMPACT
SENTIMENT
AUPH : Nasdaq
MKT Capital Pleased with Aurinia’s Commencement of a Strategic Review Process
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
management
IMPACT
SENTIMENT
AUPH : Nasdaq
Aurinia Showcases Three Oral Presentations for LUPKYNIS® (voclosporin) at 2023 European Renal Association Annual Meeting in Milan, Italy
Stock AUPH logo
Aurinia Pharmaceuticals Inc
Nasdaq:AUPH

AUPH Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About AUPH

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.